A new cancer treatment that uses light to target and kill only cancer cells, and is believed to have few side effects, has entered into use in Japan, in a world first.
In the treatment, called photoimmunotherapy, antibodies that bind only to cancer cells are administered to patients.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.